Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema

NCT06498050 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: intravitreal injection of Brolucizumab 6 mg in study eye

Sponsor

Guangdong Provincial People's Hospital

Collaborators

[object Object]